Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

19 February 2013: Epidemiology  

Clinical importance of pyelocalyceal dilation diagnosed by postnatal ultrasonographic screening of the urinary tract

Kristina Drnasin ABCDEFG , Mirna Saraga-Babić DEF , Marijan Saraga ACDEF

DOI: 10.12659/MSM.883786

Med Sci Monit 2013; 19:125-131

0 Comments

Abstract

BACKGROUND: Ultrasonographic (US) screening of the urinary tract (UT) in infants was used to determine if there is a connection between the frequency of pyelocaliceal dilation (PCD) in asymptomatic infants with normal antenatal US screening and occurrence of congenital anomalies of kidney and urinary tract (CAKUT) and urinary tract infections (UTI).

MATERIAL AND METHODS: US screening of the UT was performed on 1000 healthy infants, 7 days to 6 months old. Two subgroups of kidneys were described: subgroup 1 contained kidneys with anterior posterior pelvic diameter (APPD) of 5–9.9 mm, and subgroup 2 with APPD over 10 mm. US examinations and methods for detection of UTI and CAKUT were used.

RESULTS: PCD was found in 74 infants (7.4%): 1.9% of infants had CAKUT, and 8.4% had UTI. In subgroup 1, CAKUT was found in 4 (6.3%) and UTI in 9 (14.3%) infants. In subgroup 2, CAKUT was found in 6 (54.5%), and UTI in 4 (36.4%) infants.

CONCLUSIONS: Mild PCD significantly increases the risk for CAKUT but not for UTI. Moderate to severe PCD significantly increases risk for both CAKUT and UTI. The postnatal US screening of UT is recommended for improved detection of PCD and associated CAKUT. Indirectly, postnatal US screening of UT can help in detecting people at risk for UTI in the first year of life, and therefore help prevent possible kidney damage.

Keywords: Body Fluids - analysis, Carbon Dioxide - blood, Aldehyde Oxidoreductases - metabolism, Urinary Tract Infections - ultrasonography, Urinary Tract - ultrasonography, Prone Position, Neonatal Screening, Kidney - ultrasonography, Infant, Newborn, Incidence, Dilatation, Pathologic - ultrasonography, Croatia - epidemiology, Case-Control Studies, Formates - poisoning, Haplorhini, Hydrogen-Ion Concentration, Kinetics, Methanol - blood, Methods, Pseudomonas - enzymology

Background

Hydronephrosis is the dilation of the renal collecting system, which is often, but not always, associated with an obstruction, a vesicoureteric reflux, or an abnormal development of the ureteric morphology. Any underdevelopment of the urinary tract can cause its temporary or permanent dilation. Thus, finding a difference between a transitory and permanent dilation of the renal collecting system could be a real diagnostic challenge [1,2]. US (ultrasound) screening is a very sensitive method for the detection of hydronephrosis. There are several common methods used for grading the intensity of hydronephrosis, which is based either on a structural illustration of the renal collecting system, or on measuring the anterior posterior pelvic diameter (APPD). According to the Society of Fetal Urology (SFU), there are 4 grades of hydronephrosis, ranging from grade 0 to grade 4 [3–8]. Other grading systems for determining the intensity of hydronephrosis include measuring APPD, such as the Grignon (1986) grading system [7] or the Blachar (1994) grading system [8]. Grignon’s grading system discriminates 5 degrees of hydronephrosis, and Blachar’s grading system classifies hydronephrosis from grades 0 to 3 [7,8]. In fetuses, renal pelvic diameter greater than 10 mm may suggest an obstructive uropathy or an unusual extrarenal pelvis [9]. However, even a narrower renal pelvic diameter can be clinically significant if it is connected to the enlargement of renal calyces [3]. Because the enlargement of the renal collecting system may indicate various associated congenital anomalies of kidneys and urinary tract (CAKUT), in some countries prenatal and postnatal US screening of the urinary tract is regularly performed [3,10–14]. Antenatal hydronephrosis is positively diagnosed in 1–5% of pregnancies, but about 20% of the anomalies that are recorded during intrauterine development are not present after birth [15]. Children with prenatal hydronephrosis of any grade had a greater risk of an associated CAKUT than children with normal prenatal US of the urinary tract. Moreover, the risk for a postnatal pathology increased significantly with the grade of antenatal hydronephrosis [16]. Capolicchio et al. (1999) suggested that patients with prenatally diagnosed hydronephrosis using US screening had less chance of having kidney damage and a better chance for early surgical intervention than patients with postnatally diagnosed hydronephrosis [17]. On the other hand, 10%–20% of the hydronephrosis detected postnatally was not seen during the prenatal US screening [15]. According to various authors, postnatal US screening should be done between the third and tenth day after birth in order to avoid a state of relative dehydration and physiologic oliguria within the first days of life. This can cause an underestimation of the degree of hydronephrosis, resulting in a false-negative diagnosis [18–20]. Hydronephrosis and obstruction of the urinary system seem to be closely connected, although hydronephrosis can occur without a clinically significant obstruction. Nonetheless, hydronephrosis certainly represents an abnormal state and its presence can lead to kidney damage. Therefore, prenatally or postnatally diagnosed hydronephrosis must be followed up in order to detect those infants with severe obstructive dilation and, if necessary, treat them by surgical or endoscopic procedures before any irreversible kidney damage or deterioration of renal function occurs [18,21–26].

The aim of our study was to detect the number of hydronephroses, diagnosed by postnatal US screening, that remained unrecognized by prenatal US screening, as well as to explore their possible connection with other CAKUT and urinary tract infection (UTI).

Material and Methods

STATISTICAL ANALYSIS:

The statistical package STATISTICA 7.0 was used in analyzing data. We used χ2 test, Fisher exact test and the Mann-Whitney test. We interpreted the results with a significance level of p<0.05.

Results

MAIN GROUP:

In the main group of 1000 infants tested by postnatal US screening, PCD was detected in 74 (7.4%) children (46 males, 28 females); 3 had bilateral PCD. Out of 511 examined males, 46 had PCD, and 28 out of 489 females had PCD (χ2=3.91; p=0.048). In this group, UTI was detected in 84 (8.4%) children (44 males, 40 females) (Figure 2). There were no significant difference for UTI between sexes (χ2=0.06; p=0.806). Associated CAKUT were also detected in 19 (1.9%) children (12 males, 7 females) (Figure 3). There were no significant difference for CAKUT between sexes (χ2=1.13; p=0.289).

PCD GROUP:

From this group of 74 patients with PCDs, 13 children (17.6%) had a UTI during the observed period, while 10 children (13.5%) were diagnosed with an associated CAKUT.

Out of 77 PCDs, 49 PCDs were positioned on the left side and 28 on the right side. This data showed that left side was significantly more affected by PCD than the right side (χ2=5.7; p=0.017). Out of them, 16 remained the same (20.8%), 3 PCDs (3.9%) decreased, and 58 PCDs (75.3%) had their collecting systems normalized during the observation period.

Subgroup 1 consisted of 63 children (35 males and 28 females). Two children from this group had PCD on both sides, and the others had unilateral PCDs. PCD on the left side was 1.7 times significantly (χ2=4,45;p= 0.035) more frequent than on the right side (41:24). In this subgroup, 9 (14.3%) had a UTI during the observed period, and 4 (6.3%) children had associated CAKUT (1 hydrocalyses, 1duplication of the renal collecting system, 1 vesicoureteric reflux grade 3, and 1 renal hypoplasia) (Figures 2 and 3). In the follow-up screenings, 11 PCDs (16.9%) remained the same, and in the remaining group of 54 (83.1%), PCDs had disappeared. No patient from that group had any surgical intervention (Figure 4).

Subgroup 2 consisted of 11 children (all males). One of the observed patients had PCD on both sides, and the others had PCD on only 1 side. Even though the enlargement was dominant on the left side (8:4), there was no statistical significance regarding affected sides (χ2=1.3; p=0.248). In this subgroup, 4 (36.4%) children acquired a UTI during the observation period, and 6 children (54.5%) had an associated CAKUT (Figures 2 and 3). During the period of our study, 5 (41.7%) collecting systems remained unchanged, 3 (25%) had a decrease of PCD, and 4 (33.3%) collecting systems had normalized (Figure 5). Altogether, only 3 children underwent surgery.

CONTROL GROUP:

In the control group of 926 children, UTI was detected in 71 (7.7%) children, and CAKUT was discovered by US screening in 9 (1.0%) children (Figures 2 and 3).

COMPARISON BETWEEN THE GROUPS:

In the group of patients with PCD, UTI was 2.3 times more frequent than in the control group2=8.73; p=0.003), and CAKUT was 15 times more frequent (χ2=58; p<0.001).

In the subgroup1,UTI was not significantly more frequent than in the control group2=3.46; p=0.063), but UTI was significantly more frequent in subgroup 2 than in the control group2=44.5; p<0.001). CAKUT was significantly more frequent in subgroup 12=13.1; p<0.001) and in subgroup 22=198; p<0.001) than in the control group.

:

A statistically significant difference was found between subgroup 1 and subgroup 2 regarding sex (χ2=7.9; p=0.005) due to the fact that subgroup 2 consisted of males only. Although the children in subgroup 2 had 2.5 times greater occurrence of UTI than children in subgroup 1, it was statistically insignificant (Fisher exact test: p=0.094) due to the small sample size in subgroup 2. At the same time, a statistically significant difference in the number of associated CAKUT between the 2 subgroups was noted. Children in subgroup 2 had an 8.6 times greater occurrence of CAKUT than in subgroup 12=18.6, p<0.001). Normalization of the renal collecting system was 2.5 times more frequent in subgroup 1 than in subgroup 2 (Fisher exact test: p=0.037) (χ2=13.5, p<0.001).

Discussion

RECOVERY RATES OF PCD DURING THE OBSERVATION TIME:

An analysis of a number of studies has shown that the majority of mild degree hydronephroses at first stabilized and eventually disappeared. This especially refers to those from SFU’s first and second degrees, in contrast to hydronephrosis of third and fourth degree [4]. Dremsek et al. (1997) concluded that an APPD less than 10 mm on a neonatal sonogram does not necessarily mean a pathological change, because the size of the urinary tract often spontaneously retracts to normal within the first year of life [29]. Our study showed that overall recovery rate of PCD was 79.2%, and Padovani’s study showed that 72.3% of all PCDs spontaneously disappeared (90% in G I, 73% in G II and 58% in G III). Only 1 GIII patient showed a progressive dilation. Out of 17 newborns,15 displayed severe hydronephrosis (G IV–G V) and had regular follow-ups. Among them, 7 spontaneously recovered and 4 achieved complete resolution [27]. Regarding the recovery rate of mild PCD (subgroup 1), our study showed an 83.1% resolution, compared to 90% from Padovani’s study. Moderate and severe PCDs from our study (subgroup 2) had a lower percentage of normalization (58.3%) in contrast to Padovan’s study [27]. Bereczki et al. (2004) observed that 49.8% of the recorded dilations completely disappeared, 42.2% remained the same, and 7.4% increased (more than 30 mm) [30]. This recovering tendency of PCD was also noted by Lee et al. (2004), who showed that dilations of the collecting system are often likely to decrease, and very rarely become enlarged [31]. Sidhu et al. (2006) found that 98% of infants who had prenatal idiopathic hydronephrosis with a lower degree of dilation (APPD less than 12 mm), decreased their dilation to a normal level over time. This was not the case in infants with greater degrees of dilation (APD greater than 12 mm), in whom only 51% of cases normalized over time [4]. Some of the controversial results regarding the percentage of disappearing dilations might be the result of different criteria for hydronephrosis, expertise of pediatricians and gynecologists performing the US examination, and precision level of US screening equipment.

CAKUT IN CHILDREN WITH PCD:

Our results suggest that all children from our study with PCDs, regardless of grade, need further CAKUT observation, because we discovered a 15 times higher risk for associated CAKUT in that group than in the rest of the population. In children with mild PCD (subgroup 1) that risk was 6.3 times greater. Special attention should be paid to children with higher grades of PCDs because they had 8.6 times higher risk for associated CAKUT than those with mild PCD. Similar to our study, Coelho et al. (2007), Tsai et al. (1998), and Grazioli et al. (2010) showed that the percentage of associated CAKUT positively correlated with the degree of hydronephrosis [10,32,33].

UTI IN CHILDREN WITH PCD:

It has already been well documented that infants with postnatal PCD have an increased risk of UTI [34,35].

In our study, the occurrence of UTI in children with PCD, regardless of grade, was 17.6%. Our results also point out that children having mild dilation of the pyelocaliceal system (subgroup 1) actually do not need further observation regarding UTI, because we did not discover significantly greater occurrence of UTI in this group than in the rest of the population, which is in accordance with results of Dremsek et al. (1997) and Tabel et al. (2010) [29,36].

Mami et al. (2009) did not find any significant difference in UTI frequency between infants with moderate PCD (APD 10–15 mm) and infants of the control group [13]. However, another study by the same authors showed a significantly higher incidence of UTI in infants with isolated severe renal pelvic dilation (APD >15 ≤20 mm) than in infants of the control group [14].

Higher grades of PCDs from our study positively correlated with number of UTIs, what is in accordance with findings of Tabel et al. (2010) and Coelho et al. (2007) [10,36]. That data indicate that postnatally screened children with high grade of PCD should be carefully monitored for UTI and should be protected by long-term uroantiseptic prophylaxis in their first year of life, but those with mild PCD-s should be treated like other healthy children. In addition to the fact that the children in our study were likely to have a UTI proportionate to their intensity of PCD, we recommend further diagnostic treatment in the case of constant or increased PCD during examinations. All data from our study indicate that patients with high grades of PCDs have to be carefully monitored for UTI and associated CAKUT, but patients with lower grades of PCDs have to be monitored for associated CAKUT only.

NECESSITY OF POSTNATAL US SCREENING OF URINARY SYSTEM:

In the past, patients with hydronephrosis were often diagnosed postnatally, but only when a palpable mass was discovered in the abdomen or when patients had already been affected by UTI and had to undergo a diagnostic procedure. Today, the use of ultrasonographic imaging has allowed great progress in diagnosing urinary system anomalies. Prenatal US screening of the urinary system proved not to be sensitive enough due to many subjective and objective factors [29,36,37]. Nevertheless, this method successfully diagnosed many cases of hydronephrosis in utero. To date, several studies on postnatal US screening have been performed. Among all CAKUT diagnosed by postnatal US screening, only 15.2% and 39% were found prenatally [29,30,38]. German authors computed the sensitivity of prenatal US screening to be 36%, and the accuracy rate was 99% [37]. This data suggests that every infant could benefit from both a prenatal and postnatal US screening of the urinary tract, as it enables prompt detection of any CAKUT.

Our experience with prenatal US screening has also shown an insufficiency in diagnosing urinary tract dilations, and shows the importance of screening children postnatally as well. Our investigation has proven that postnatally screened children showed an additional 7.4% more PCDs, even though their prenatal sonograms were declared normal. Padovani et al. (1996) found 7.1% PCDs (APPD >5 mm) in a group of 1881 healthy newborns, which is similar to our findings [27]. Contrary to our results, Tsai et al. (1998) found 17.7% PCDs (9.6% mild dilation and 8.1% hydronephrosis) in a group of 2384 healthy asymptomatic newborns, which is a much higher percentage than in our study. This is probably due to differences in criteria of each study, such as the fact that they assumed every visible collecting system to be pathologically enlarged [32]. The results of all these studies lead to the conclusion that prenatal US screening of the urinary tract is insufficient for a good diagnosis of PCD and needs to be complemented with a postnatal US screening.

Conclusions

The postnatal US screening of the urinary system is a useful and valuable method for detecting PCDs. It can uncover additional instances of PCDs, which were not seen in prenatal US screening. Our results indicate that mild cases of PCD in infants significantly increase the risk for CAKUT, but not for UTI. Moderate and severe cases of PCD raise the risk for CAKUT and for UTI. Early diagnosis and early treatment of CAKUT, as well as watchfulness for possible UTI should be the final goal in kidney damage prevention. Therefore, we recommend that postnatal US screening of the urinary system should be done in all children in the first months of life, preferably together with ultrasonographic screening of the hips.

References

1. Mouriquand PDE, Troisfontaines E, Wilcox DT, Antenatal and perinatal uro-nephrology: current questions and dilemmas: Pediatr Nephrol, 1999; 13; 938-44, pmid: 10603156

2. Adra AM, Mejides AA, Dennaoui MS, Beydoun SN, Fetal pyelectasis: is it always „physiologic“?: Am J Obstet Gynecol, 1995; 173(4); 1263-66, pmid: 7485334

3. Yice J, Wilcox D, Management of fetal hydronephrosis: Pediatr Nephrol, 2008; 23; 347-53, pmid: 17671800

4. Sidhu G, Beyene J, Rosenblum ND, Outcome of isolated antenatal hydronephrosis: a systematic review and meta-analysis: Pediatr Nephrol, 2006; 21; 218-24, pmid: 16362721

5. Kletscher B, deBadiola F, Gonzalesz R, Outcome of hydronephrosis diagnosed antenatally: J Pediatr Surg, 1991; 26(4); 455-60, pmid: 2056407

6. Fernbach SK, Maizels M, Conway JJ, Ultrasound grading of hydronephrosis: introduction to the system used by the Society for Fetal Urology: Pediatr Radiol, 1993; 23; 478-80, pmid: 8255658

7. Grignon A, Filion R, Filiatrault D, Urinary tract dilatation in utero: classification and clinical applications: Radiology, 1986; 160; 645-47, pmid: 3526402

8. Blachar A, Blachar Y, Livne PM, Clinical outcome and follow-up of prenatal hydronephrosis: Pediatr Nephrol, 1994; 8; 30-35, pmid: 8142221

9. Arger PH, Coleman BG, Mintz MC, Routine fetal genitourinary tract screening: Radiology, 1985; 156; 485-89, pmid: 3892578

10. Coelho GM, Bouzada MCF, Pereira AK, Outcome of isolated antenatal hydronephrosis: a prospective cohort study: Pediatr Nephrol, 2007; 22; 1727-34, pmid: 17653772

11. Pates JA, Dashe JS, Prenatal diagnosis and management of hydronephrosis: Early Hum Dev, 2006; 82(1); 3-8, pmid: 16380224

12. Berrocal T, Pinilla I, Gutierrez J, Mild hydronephrosis in newborn and infants: can ultrasound predict the presence of vesicoureteral reflux: Pediatr Nephrol, 2007; 22; 91-96, pmid: 16967282

13. Mamì C, Paolata A, Palmara A, Outcome and management of isolated moderate renal pelvis dilatation detected at postnatal screening: Pediatr Nephrol, 2009; 24; 2005-8, pmid: 19582482

14. Mamì C, Palmara A, Paolata A, Outcome and management of isolated severe renal pelvis dilatation detected at postnatal screening: Pediatr Nephrol, 2010; 25; 2093-97, pmid: 20556430

15. Ebel KD, Uroradiology in the fetus and newborn: diagnosis and follow-up of congenital obstruction of the urinary tract: Pediatr Radiol, 1998; 28; 630-35, pmid: 9716640

16. Lee RS, Cendron M, Kinnamon DD, Nguyen HT, Antenatal hydronephrosis as a predictor of postnatal outcome: a meta-analysis: Pediatrics, 2006; 118; 586-93, pmid: 16882811

17. Capolicchio G, Leonard MP, Wong C, Prenatal diagnosis of hydronephrosis: Impact on renal function and its recovery after pyeloplasty: J Urol, 1999; 162; 1029-32, pmid: 10458425

18. Riccabona M, Assessment and management of newborn hydronephrosis: World J Urol, 2004; 22(2); 73-78, pmid: 15197477

19. Fong KW, Ryan G, The fetal urogenital tract: Diagnostic ultrasound 1 and 2, 1998; 1093-121, St. Louis, Missouri, Mosby

20. Wiener JS, O’Hara SM, Optimal timing of initial postnatal ultrasonography in newborn with prenatal hydronephrosis: J Urol, 2002; 168; 1826-29, pmid: 12352369

21. Belarmino JM, Kogan BA, Management of neonatal hydronephrosis: Early Hum Dev, 2006; 82(1); 9-14, pmid: 16427220

22. Gramellini D, Fieni S, Caforio E, Diagnostic accuracy of fetal renal pelvis anteroposterior diameter as a predictor of significant postnatal nephrouropathy: second versus third trimester of pregnancy: Am J Obstet Gynecol, 2006; 194(1); 167-73, pmid: 16389027

23. Coplen DE, Austin PF, Yan Y, The magnitude of fetal renal pelvic dilatation can identify obstructive postnatal hydronephrosis, and direct postnatal evaluation and management: J Urol, 2006; 176(2); 724-27, pmid: 16813930

24. Ciardelli V, Rizzo N, Lanari M, Ultrasound screening for congenital pyelectasis in term pregnancies: Am J Perinatol, 2005; 22(5); 265-67, pmid: 16041637

25. Odibo AO, Raab E, Elovitz M, Prenatal mild pyelectasis: evaluating the thresholds of renal pelvic diameter associated with normal postnatal renal function: J Ultrasound Med, 2004; 23(4); 513-17, pmid: 15098870

26. John U, Kahler C, Schulz S, The impact of fetal renal pelvic diameter on postnatal outcome: Prenat Diagn, 2004; 24(8); 591-95, pmid: 15305344

27. Padovani EM, Bergamo AIA, Khoory BJ, Neonatal ultrasonic screening and follow up of urinary tract malformations: Pediatr Med Chir, 1996; 18(1); 37-41, pmid: 8685021

28. Ilić T, Gračan S, Arapović A, Changes in bacterial resistance patterns in children with urinary tract infections on antimicrobial prophylaxis at University Hospital in Split: Med Sci Monit, 2011; 17(7); CR355-61, pmid: 21709628

29. Dremsek PA, Gindl K, Voitl P, Renal pyelectasis in fetuses and neonates: diagnostic value of renal pelvis diameter in pre- and postnatal sonographic screening: Am J Roentgenol, 1997; 168(4); 1017-19, pmid: 9124107

30. Bereczki CS, Orvos H, Sumegi V, Postnatal renal pelvis dilatation – results of 9650 screened neonates (Abstr): Pediatr Nephrol, 2004; 19; C217

31. Lee KW, Sit KC, Chu SK, Postnatal outcome of antenatal hydronephrosis (Abstr): Pediatr Nephrol, 2004; 19; C218

32. Tsai JD, Huang FY, Tsai TC, Asymptomatic vesicoureteral reflux detected by neonatal ultrasonographic screening: Pediatr Nephrol, 1998; 12; 206-9, pmid: 9630038

33. Grazioli S, Parvex P, Merlini L, Antenatal and postnatal ultrasound in the evaluation of the risk of vesicoureteral reflux: Pediatr Nephrol, 2010; 25; 1687-93, pmid: 20524012

34. Lee JH, Choi HS, Kim JK, Nonrefluxing neonatal hydronephrosis and the risk of urinary tract infection: J Urol, 2008; 179(4); 1524-28, pmid: 18295269

35. Anderson NG, Fischer J, Leighton D, Management in children of mild postnatal renal dilatation but without vesivoureteral reflux: Pediatr Nephrol, 2010; 25; 477-83, pmid: 19921278

36. Tabel Y, Haskologlu ZS, Karakas HM, Yakinci C, Ultrasonographic screening of newborns for congenital anomalies of the kidney and the urinary tracts: Urol J, 2010; 7; 161-67, pmid: 20845291

37. Stolz G, Schumacher R, Wiesel A, Pre- and postnatal kidney screening compared: an analysis of 34,450 newborn infants of the Mainz model birth register: Radiologe, 2002; 42(8); 630-36, pmid: 12426742

38. Miyakita H, Ueno S, Nomura M, Neonatal hydronephrosis detected on routine health check-up: Tokai J Exp Clin Med, 2001; 26(3); 101-5, pmid: 11885751

In Press

Clinical Research  

Institutional and Regional Variations in Access to Clinical Trials and Next-Generation Sequencing in Turkis...

Med Sci Monit In Press; DOI: 10.12659/MSM.951027  

Clinical Research  

Low-Intensity Blood Flow-Restricted Multi-Joint Exercise Improves Muscle Function in Patients With Patellof...

Med Sci Monit In Press; DOI: 10.12659/MSM.950516  

Review article  

Musculoskeletal Ultrasound and MRI in the Evaluation of Chemotherapy-Induced Peripheral Neuropathy: A Review

Med Sci Monit In Press; DOI: 10.12659/MSM.951283  

Clinical Research  

Sensory Processing, Dissociation, and Affective Symptoms in Misophonia: A Cross-Sectional Study of 35 Adults

Med Sci Monit In Press; DOI: 10.12659/MSM.950938  

Most Viewed Current Articles

17 Jan 2024 : Review article   10,187,196

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

13 Nov 2021 : Clinical Research   3,708,487

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788

0:00

14 Dec 2022 : Clinical Research   2,341,643

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research   706,524

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750